Somewhere along the way, the PREVAIL phase 3 endpoint got pushed out a year. But now they intend to conduct an interim analysis in 4q26, reported 1q27. (Listening to analyst call, they’re quite confident about this timeline.) No indication when it will be for sale in the US. (Coming to EU before end of year.)
2 Likes